Parafibromin is a component of IFN-γ-triggered signaling pathways that facilitates JAK1/2-mediated tyrosine phosphorylation of STAT1

Journal of Immunology

Volumn 195, Issue 6, 2015, Pages 2870-2878

  Wei, Jin ^a   Lian, Huan ^a   Zhong, Bo ^a   Shu, Hong Bing ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; JANUS KINASE 1; JANUS KINASE 2; PARAFIBROMIN; REGULATOR PROTEIN; STAT1 PROTEIN; TYROSINE; UNCLASSIFIED DRUG; CDC73 PROTEIN, HUMAN; DNA BINDING PROTEIN; JAK1 PROTEIN, HUMAN; JAK2 PROTEIN, HUMAN; SMALL INTERFERING RNA; STAT1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL FRACTIONATION; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; CELL LINE; ENZYME ACTIVATION; GENETICS; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; RNA INTERFERENCE;

CELL LINE; DNA-BINDING PROTEINS; ENZYME ACTIVATION; HEK293 CELLS; HUMANS; INTERFERON-GAMMA; JANUS KINASE 1; JANUS KINASE 2; PHOSPHORYLATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEINS;

EID: 84941781999     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501111     Document Type: Article

References (28)

1. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-g and its receptor. Annu. Rev. Immunol. 11: 571-611.
2. Ramana, C. V., M. P. Gil, R. D. Schreiber, and G. R. Stark. 2002. Stat1-dependent and -independent pathways in IFN-g-dependent signaling. Trends Immunol. 23: 96-101.
3. Hu, X., and L. B. Ivashkiv. 2009. Cross-regulation of signaling pathways by interferon-g: implications for immune responses and autoimmune diseases. Immunity 31: 539-550.
4. Valente, G., L. Ozmen, F. Novelli, M. Geuna, G. Palestro, G. Forni, and G. Garotta. 1992. Distribution of interferon-g receptor in human tissues. Eur. J. Immunol. 22: 2403-2412.
5. Stark, G. R., and J. E. Darnell, Jr. 2012. The JAK-STAT pathway at twenty. Immunity 36: 503-514.
6. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67: 227-264.
7. Wen, Z., Z. Zhong, and J. E. Darnell, Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250.
8. Decker, T., and P. Kovarik. 2000. Serine phosphorylation of STATs. Oncogene 19: 2628-2637.
9. Srivastava, K. K., S. Batra, A. Sassano, Y. Li, B. Majchrzak, H. Kiyokawa, A. Altman, E. N. N. Fish, and L. C. Platanias. 2004. Engagement of protein kinase C-u in interferon signaling in T-cells. J. Biol. Chem. 279: 29911-29920.
10. Carpten, J. D., C. M. Robbins, A. Villablanca, L. Forsberg, S. Presciuttini, J. Bailey-Wilson, W. F. Simonds, E. M. Gillanders, A. M. Kennedy, J. D. Chen, et al. 2002. HRPT2, encoding parafibromin, is mutated in hyperparathyroidismjaw tumor syndrome. Nat. Genet. 32: 676-680.
11. Shattuck, T. M., S. Välimäki, T. Obara, R. D. Gaz, O. H. Clark, D. Shoback, M. E. Wierman, K. Tojo, C. M. Robbins, J. D. Carpten, et al. 2003. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N. Engl. J. Med. 349: 1722-1729.
12. Rondón, A. G., M. Gallardo, M. García-Rubio, and A. Aguilera. 2004. Molecular evidence indicating that the yeast PAF complex is required for transcription elongation. EMBO Rep. 5: 47-53.
13. Lin, L., J. H. Zhang, L. M. Panicker, and W. F. Simonds. 2008. The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene. Proc. Natl. Acad. Sci. USA 105: 17420-17425.
14. Yang, Y. J., J. W. Han, H. D. Youn, and E. J. Cho. 2010. The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression. Nucleic Acids Res. 38: 382-390.
15. Yart, A., M. Gstaiger, C. Wirbelauer, M. Pecnik, D. Anastasiou, D. Hess, and W. Krek. 2005. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol. Cell. Biol. 25: 5052-5060.
16. Woodard, G. E., L. Lin, J. H. Zhang, S. K. Agarwal, S. J. Marx, and W. F. Simonds. 2005. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Oncogene 24: 1272-1276.
17. Zhang, J. H., L. M. Panicker, E. M. Seigneur, L. Lin, C. D. House, W. Morgan, W. C. Chen, H. Mehta, M. Haj-Ali, Z. X. Yu, and W. F. Simonds. 2010. Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73. Cell Death Differ. 17: 1551-1565.
18. Xu, L. G., Y. Y. Wang, K. J. Han, L. Y. Li, Z. Zhai, and H. B. Shu. 2005. VISA is an adapter protein required for virus-triggered IFN-b signaling. Mol. Cell 19: 727-740.
19. Zhong, B., Y. Yang, S. Li, Y. Y. Wang, Y. Li, F. Diao, C. Lei, X. He, L. Zhang, P. Tien, and H. B. Shu. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29: 538-550.
20. Zhong, B., L. Zhang, C. Lei, Y. Li, A. P. Mao, Y. Yang, Y. Y. Wang, X. L. Zhang, and H. B. Shu. 2009. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 30: 397-407.
21. Lei, C. Q., B. Zhong, Y. Zhang, J. Zhang, S. Wang, and H. B. Shu. 2010. Glycogen synthase kinase 3b regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. Immunity 33: 878-889.
22. Zhong, B., Y. Zhang, B. Tan, T. T. Liu, Y. Y. Wang, and H. B. Shu. 2010. The E3 ubiquitin ligase RNF5 targets virus-induced signaling adaptor for ubiquitination and degradation. J. Immunol. 184: 6249-6255.
23. Zhou, Q., H. Lin, S. Wang, S. Wang, Y. Ran, Y. Liu, W. Ye, X. Xiong, B. Zhong, H. B. Shu, and Y. Y. Wang. 2014. The ER-associated protein ZDHHC1 is a positive regulator of DNA virus-triggered, MITA/STING-dependent innate immune signaling. Cell Host Microbe 16: 450-461.
24. Sims, S. H., Y. Cha, M. F. Romine, P. Q. Gao, K. Gottlieb, and A. B. Deisseroth. 1993. A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol. Cell. Biol. 13: 690-702.
25. Rozenblatt-Rosen, O., C. M. Hughes, S. J. Nannepaga, K. S. Shanmugam, T. D. Copeland, T. Guszczynski, J. H. Resau, and M. Meyerson. 2005. The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol. Cell. Biol. 25: 612-620.
26. Hahn, M. A., and D. J. Marsh. 2005. Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin. Oncogene 24: 6241-6248.
27. Bach, E. A., J. W. Tanner, S. Marsters, A. Ashkenazi, M. Aguet, A. S. Shaw, and R. D. Schreiber. 1996. Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Mol. Cell. Biol. 16: 3214-3221.
28. Müller, M., J. Briscoe, C. Laxton, D. Guschin, A. Ziemiecki, O. Silvennoinen, A. G. Harpur, G. Barbieri, B. A. Witthuhn, C. Schindler, et al. 1993. The protein tyrosine kinase JAK1 complements defects in interferon-a/b and -g signal transduction. Nature 366: 129-135.